Skip to content

Clinical trials

Completed Metabolic Diseases trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Metabolic Diseases Status: Completed Country / region: Russia Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20093
20101
20141
20161
20181
20204
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
AO GENERIUM2
Eli Lilly and Company2
Alexion Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
POLYSAN Scientific & Technological Pharmaceutical Company1
Rezolute1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Metabolic Diseases13
Diabetes Mellitus, Type 28
Glucose Metabolism Disorders7
Diabetes Mellitus6
Endocrine System Diseases5
Genetic Diseases, Inborn3
Lysosomal Storage Diseases3
Genetic Diseases, X-Linked2
Mucopolysaccharidoses2
Mucopolysaccharidosis II2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.